Condensed Consolidated and Combined Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Cash flows from operating activities
Net income (loss)	$ 46,816	$ (38,518)
Adjustments to reconcile combined net income to net cash provided by (used in) operating activities:
Bad debt expense	298	1,682
Depreciation and amortization	1,308	1,094
(Income) loss from equity method investments	(3,060)	4,071
Equity-based compensation	20,518	106,238
Deferred tax provision	1,092	(252)
Other	(3)	3,383
Changes in assets and liabilities:
Accounts receivable	726	3,830
Other receivables	(5,204)	(7,978)
Prepaid expenses and other assets	(1,797)	(1,108)
Deferred compensation	(1,121)	(1,176)
Compensation payable	(89,844)	(31,786)
Accounts payable and accrued expenses	(2,285)	1,319
Deferred revenue	2,778	1,320
Dividends received	985
Other liabilities	413	697
Net cash provided by (used in) operating activities	(28,380)	42,816
Cash flows from investing activities
Purchase of investments	(26,994)	(20,917)
Proceeds from sales of investments	39,999	83,237
Return of capital from equity method investments	109
Investment in equity method investments		(4,445)
Note payments received from employees		831
Purchase of equipment and leasehold improvements	(2,102)	(789)
Change in restricted cash	(68)	(1)
Net cash provided by (used in) investing activities	10,944	57,916
Cash flows from financing activities
Pre-offering distribution to partners		(195,017)
Dividends and distributions	(47,754)	(46,748)
IPO related proceeds (net of $5,711 of offering costs)		168,287
Distributions of IPO proceeds to partners		(139,429)
Other cash contributions from (distributions to) Parent		(34,730)
Purchase of treasury stock	(5,953)
Cash proceeds from issuance of Class B common stock		500
Class A partnership units and other equity purchased	(90)
Net cash provided by (used in) financing activities	(53,797)	(247,137)
Effect of exchange rate fluctuations on cash and cash equivalents	924	1,387
Net increase (decrease) in cash and cash equivalents	(70,309)	(145,018)
Cash and cash equivalents, beginning of period	197,944	303,024
Cash and cash equivalents, end of period	127,635	158,006
Cash paid during the period for:
Income taxes	11,904	2,228
Other non-cash activity
Initial establishment of deferred tax assets, net of amounts payable		10,854
Capitalized offering costs paid in prior or subsequent period		6,180
Tax benefit related to settlement of appreciation units		4,308
Establishment of deferred tax asset related to reorganization		3,261
Increase in deferred tax asset related to IPO		1,302
Other non-cash distributions		$ 1,105
Class A Partnership Units or other equity converted into Class A Common Stock	3,644
Dividend equivalents issued	1,339
Net tax benefit from the delivery of restricted stock units and payment of dividend equivalents	$ 47